26 February 2007
BOARD CHANGE
DAVID TYLER APPOINTED NON-EXECUTIVE DIRECTOR
Reckitt Benckiser plc (RB.L) today announced the appointment of David Tyler as
an independent non-executive director.
David Tyler (54) was Group Finance Director of GUS plc from February 1997 until
October 2006. In addition to his financial role at GUS plc, he was responsible
for the development of group strategy. Prior to joining GUS plc, he was Group
Finance Director of Christie's International plc and in his early career he
held positions within County NatWest Ltd and Unilever plc. He is a Fellow of
the Chartered Institute of Management Accountants and a Member of the
Association of Corporate Treasurers. He is currently a non-executive director
of Burberry Group and Experian Group.
Adrian Bellamy, Chairman of Reckitt Benckiser plc, commented
"The Board is delighted that David has agreed to join us. He will bring a
wealth of financial and business experience to the Board. I am sure he will
make a significant contribution to the future success of the Company."
For Further Information
Tom Corran, SVP Investor Relations & Corporate Communications
Telephone +44 (0) 1753 217 800
Liz Richardson , Company Secretary
Telephone +44 (0) 1753 217 800
Fiona Fong, Head of Corporate Communications
Telephone + 44 (0) 1753 217 800
Notes for Editors
Reckitt Benckiser is the world leader in household cleaning, excluding laundry,
and has a major presence in health and personal care. The Company has
operations in 60 countries, sales in 180 and employs 22,000 people around the
world. Amongst the Company's leading brands are Lysol, the world leader in
disinfecting cleaning, Calgonit, Finish and Electrasol, the world leaders in
automatic dishwashing, Woolite, world leader in garment care, Vanish & Spray 'n
Wash, world leaders in fabric treatment; and Airwick and Mortein, number two
brands in air care and pest control. In health and personal care leading brands
include: Veet, the world number one depilatory, Dettol the world's leading
antiseptic, Strepsils, the world number one sore throat tablet, Nurofen, the
number two analgesic worldwide, and Clearasil, the world's leading anti-acne
treatment.
Reckitt Benckiser is headquartered in Slough just outside London and is listed
on the London stock exchange. With a market capitalization of c.£18bn it ranks
among the top 30 UK listed companies.. Reckitt Benckiser had net revenues of £
4.9bn, operating profit of £1,059m, and net income of £786m in 2006.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.